European Union - English - EMA (European Medicines Agency)

eli lilly nederland b.v. - insulin lispro - diabetes mellitus - drugs used in diabetes - treatment of diabetes mellitus in adults, adolescents and children aged 1 year and above.treatment of diabetes mellitus in adults.

European Union - English - EMA (European Medicines Agency)

eli lilly nederland b.v. - selpercatinib - carcinoma, non-small-cell lung; thyroid neoplasms - antineoplastic agents - retsevmo as monotherapy is indicated for the treatment of adults and adolescents 12 years and older with advanced ret-mutant medullary thyroid cancer (mtc)advanced ret fusion-positive non-small cell lung cancer (nsclc) not previously treated with a ret inhibitoradvanced ret fusion-positive thyroid cancer who require systematic therapy following prior treatment

European Union - English - EMA (European Medicines Agency)

eli lilly nederland b.v. - tirzepatide - diabetes mellitus, type 2 - drugs used in diabetes - mounjaro is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise- as monotherapy when metformin is considered inappropriate due to intolerance or contraindications- in addition to other medicinal products for the treatment of diabetes.for study results with respect to combinations, effects on glycaemic control and the populations studied, see sections 4.4, 4.5 and 5.1.

European Union - English - EMA (European Medicines Agency)

eli lilly nederland b.v. - lasmiditan succinate - migraine disorders - analgesics - rayvow is indicated for the acute treatment of the headache phase of migraine attacks, with or without aura in adults.

European Union - English - EMA (European Medicines Agency)

eli lilly nederland b.v. - mirikizumab - colitis, ulcerative - immunosuppressants - omvoh is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a biologic treatment.

European Union - English - EMA (European Medicines Agency)

eli lilly nederland b.v. - pirtobrutinib - lymphoma, mantle-cell - protein kinase inhibitors - treatment of mantle cell lymphoma (mcl)

European Union - English - EMA (European Medicines Agency)

substipharm - prasugrel - acute coronary syndrome; angina, unstable; myocardial infarction - antithrombotic agents - efient, co-administered with acetylsalicylic acid (asa), is indicated for the prevention of atherothrombotic events in patients with acute coronary syndrome (i.e. unstable angina, non-st-segment-elevation myocardial infarction [ua / nstemi] or st-segment-elevation myocardial infarction [stemi]) undergoing primary or delayed percutaneous coronary intervention (pci).

European Union - English - EMA (European Medicines Agency)

substipharm - raloxifene hydrochloride - osteoporosis, postmenopausal - sex hormones and modulators of the genital system, - evista is indicated for the treatment and prevention of osteoporosis in post-menopausal women. a significant reduction in the incidence of vertebral, but not hip fractures has been demonstrated. when determining the choice of evista or other therapies, including oestrogens, for an individual postmenopausal woman, consideration should be given to menopausal symptoms, effects on uterine and breast tissues, and cardiovascular risks and benefits.